Earnings Preview For Emergent BioSolutions
Portfolio Pulse from Benzinga Insights
Emergent BioSolutions (NYSE:EBS) is set to release its latest quarterly earnings report on November 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.22. The company's past performance shows a trend of missing EPS estimates, which has led to significant drops in share price. The stock is currently trading at $2.35, down 81.36% over the last 52-week period.
November 07, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Emergent BioSolutions is expected to report a negative EPS of $-0.22. Given the company's history of missing EPS estimates and the subsequent negative impact on the share price, there could be potential downside risk for the stock.
Emergent BioSolutions has a history of missing EPS estimates, which has led to significant drops in its share price. Given the estimated negative EPS for the upcoming quarter, there is a high likelihood of the company missing the estimate again. This could potentially lead to a further drop in the share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100